C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

DEA Rescheduling Window Keeps TLRY, MSO Policy Risk Front‑and‑Center

DEA rescheduling proceedings and Tilray’s fiscal guidance reframe U.S. policy risk for MSOs and ancillaries; liquidity, guidance-to-cash conversion and state-by-state enforcement are the watchpoints.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.